Rocket Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $454.7M | $232.7M |
| FY2022 | — | $489.7M | $140.5M |
| FY2023 | — | $492.6M | $55.9M |
| FY2024 | — | $463.2M | $163.6M |
| FY2025 | — | $277.2M | $77.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $454.7M | $232.7M |
| FY2022 | — | $489.7M | $140.5M |
| FY2023 | — | $492.6M | $55.9M |
| FY2024 | — | $463.2M | $163.6M |
| FY2025 | — | $277.2M | $77.6M |